BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8691048)

  • 1. Anti-idiotypes against autoantibodies to procoagulant factor VIII (VIII:C) in intravenous immunoglobulins.
    Kazatchkine MD; Rossi F; Sultan Y; Nydegger U
    Int Rev Immunol; 1989; 5(2):157-63. PubMed ID: 8691048
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.
    Rossi F; Sultan Y; Kazatchkine MD
    Clin Exp Immunol; 1988 Nov; 74(2):311-6. PubMed ID: 3147154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of anti-idiotypic antibodies in a patient with a factor VIII autoantibody.
    Tiarks C; Pechet L; Humphreys RE
    Am J Hematol; 1989 Nov; 32(3):217-21. PubMed ID: 2510501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-idiotypic suppression of autoantibodies with high dose intravenous immunoglobulins.
    Kazatchkine MD
    Prog Clin Biol Res; 1990; 337():411-4. PubMed ID: 2112754
    [No Abstract]   [Full Text] [Related]  

  • 5. A monoclonal anti-idiotypic antibody against the antigen-combining site of anti-factor VIII autoantibodies defines and idiotope that is recognized by normal human polyspecific immunoglobulins for therapeutic use (IVIg).
    Dietrich G; Pereira P; Algiman M; Sultan Y; Kazatchkine MD
    J Autoimmun; 1990 Oct; 3(5):547-57. PubMed ID: 1701301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.
    Sultan Y; Kazatchkine MD; Maisonneuve P; Nydegger UE
    Lancet; 1984 Oct; 2(8406):765-8. PubMed ID: 6148519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired factor VIII inhibitor in a patient with rheumatoid arthritis].
    Ruiz-Calderón AJ; Carrasco F; Duro R; Constantino M
    Sangre (Barc); 1993 Oct; 38(5):403-5. PubMed ID: 8140505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti idiotypic recognition of auto and allo antibodies to factor VIII by immunoglobulin preparations from single blood donors and large plasma pool.
    Sultan Y; Rossi F; Kazatchkine M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):539-43. PubMed ID: 1714857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotypes to factor VIII antibodies and their possible role in the pathogenesis and treatment of factor VIII inhibitors.
    Moffat EH; Furlong RA; Dannatt AH; Bloom AL; Peake IR
    Br J Haematol; 1989 Jan; 71(1):85-90. PubMed ID: 2492821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus.
    Lafferty TE; Smith JB; Schuster SJ; DeHoratius RJ
    Arthritis Rheum; 1997 Apr; 40(4):775-8. PubMed ID: 9125263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concept of anti-idiotypic regulation of selected autoimmune diseases by intravenous immunoglobulin.
    Nydegger UE; Sultan Y; Kazatchkine MD
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S72-82. PubMed ID: 2477188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiidiotypic suppression of autoantibodies with normal polyspecific immunoglobulins.
    Rossi F; Dietrich G; Kazatchkine MD
    Res Immunol; 1989 Jan; 140(1):19-31. PubMed ID: 2499021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of disease associated autoantibodies by an immunoglobulin M- and immunoglobulin A-enriched human intravenous immunoglobulin preparation.
    Bar-Dayan Y; Bonnin E; Bloch M; Schweitzer R; Ravid M; Kazatchkine MD; Kaveri SV
    Scand J Immunol; 2000 Apr; 51(4):408-14. PubMed ID: 10736114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reactivity of a natural human monoclonal polyreactive antibody with exogenous and endogenous antigens and its possible role in an idiotypic-anti-idiotypic network].
    Roggenbuck D; Kaufmann J; Franz J; Marx U; Schoenherr G; Jahn S; Porstmann T
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):485-9. PubMed ID: 7856249
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of factor VIII inhibitors.
    Kasper CK
    Prog Hemost Thromb; 1989; 9():57-86. PubMed ID: 2492380
    [No Abstract]   [Full Text] [Related]  

  • 16. Can intravenous immunoglobulin treatment regulate autoimmune responses?
    Kaveri SV; Dietrich G; Kazatchkine MD
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):64-71. PubMed ID: 1509296
    [No Abstract]   [Full Text] [Related]  

  • 17. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.
    Sultan Y; Rossi F; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):828-31. PubMed ID: 3101065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired inhibitors.
    Cohen AJ; Kessler CM
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg).
    Dietrich G; Algiman M; Sultan Y; Nydegger UE; Kazatchkine MD
    Blood; 1992 Jun; 79(11):2946-51. PubMed ID: 1586740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
    Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
    Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.